In vitro cardiac tissue models: Current status and future prospects

Advanced Drug Delivery Reviews

Volumn 96, Issue , 2016, Pages 203-213

  Mathur, Anurag ^a,b,c   Ma, Zhen ^a,b,c   Loskill, Peter ^a,b,c   Jeeawoody, Shaheen ^a   Healy, Kevin E ^a,b,c  

^a University of California   (United States)

^b University of California Berkeley   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biomaterials; Cardiac tissue models; Disease modeling; Drug screening; In vitro cardiac tissue engineering; Regenerative medicine; Tissue engineering

Indexed keywords

BIOMATERIALS; DIAGNOSIS; HEART; PHYSIOLOGICAL MODELS; TISSUE ENGINEERING;

CARDIAC TISSUE ENGINEERING; CARDIAC TISSUES; DISEASE MODELING; DRUG SCREENING; REGENERATIVE MEDICINE;

TISSUE;

BIOMATERIAL; HYDROGEL;

BIOLOGICAL MODEL; CARDIOTOXICITY; CARDIOVASCULAR EQUIPMENT; CELL DIFFERENTIATION; CELL MATURATION; CELL STRUCTURE; CELLS BY BODY ANATOMY; CYTOLOGY; DISEASE MODEL; DRUG SCREENING; DRUG TOXICITY; HEART DISEASE; HEART FUNCTION; HEART MUSCLE CELL; HUMAN; HYDROGEL; IN VITRO STUDY; MORPHOGENESIS; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; TISSUE ENGINEERING; TISSUE REGENERATION; ANIMAL; CARDIAC MUSCLE CELL; CHEMISTRY; DEVICES; EMBRYONIC STEM CELL; HEART; PHYSIOLOGY; PROCEDURES; TISSUE SCAFFOLD; TRENDS;

ANIMALS; BIOCOMPATIBLE MATERIALS; EMBRYONIC STEM CELLS; HEART; HUMANS; HYDROGELS; MODELS, CARDIOVASCULAR; MYOCYTES, CARDIAC; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84951804391     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2015.09.011     Document Type: Review

References (108)

1. Herper M. The cost of creating a new drug now $5 billion, pushing big pharma to change. Forbes 2013, http://www.forbes.com/sites/matthewherper/2013/08/11/how-the-staggering-cost-of-inventing-new-drugs-is-shaping-the-future-of-medicine/.
2. Ferri N., Siegl P., Corsini A., Herrmann J., Lerman A., Benghozi R. Drug attrition during pre-clinical and clinical development: understanding and managing drug-induced cardiotoxicity. Pharmacol. Ther. 2013, 138(3):470-484.
3. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Blaha M.J., Dai S., Ford E.S., Fox C.S., Franco S., Fullerton H.J., Gillespie C., Hailpern S.M., Heit J.A., Howard V.J., Huffman M.D., Judd S.E., Kissela B.M., Kittner S.J., Lackland D.T., Lichtman J.H., Lisabeth L.D., Mackey R.H., Magid D.J., Marcus G.M., Marelli A., Matchar D.B., McGuire D.K., Mohler E.R., Moy C.S., Mussolino M.E., Neumar R.W., Nichol G., Pandey D.K., Paynter N.P., Reeves M.J., Sorlie P.D., Stein J., Towfighi A., Turan T.N., Virani S.S., Wong N.D., Woo D., Turner M.B., C.American Heart Association Statistics, and S.Stroke Statistics Heart disease and stroke statistics - 2014 update: a report from the American Heart Association. Circulation 2014, 129(3):e28-e292.
4. Passier R., van Laake L.W., Mummery C.L. Stem-cell-based therapy and lessons from the heart. Nature 2008, 453(7193):322-329.
5. Singhvi R., Kumar A., Lopez G.P., Stephanopoulos G.N., Wang D.I., Whitesides G.M., Ingber D.E. Engineering cell shape and function. Science 1994, 264(5159):696-698.
6. Chen C.S., Mrksich M., Huang S., Whitesides G.M., Ingber D.E. Geometric control of cell life and death. Science 1997, 276(5317):1425-1428.
7. Shao Y., Sang J., Fu J. On human pluripotent stem cell control: The rise of 3D bioengineering and mechanobiology. Biomaterials 2015, 52:26-43.
8. Weaver V.M., Fischer A.H., Peterson O.W., Bissell M.J. The importance of the microenvironment in breast cancer progression: recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay. Biochem. Cell Biol. 1996, 74(6):833-851.
9. Bouten C.V., Dankers P.Y., Driessen-Mol A., Pedron S., Brizard A.M., Baaijens F.P. Substrates for cardiovascular tissue engineering. Adv. Drug Deliv. Rev. 2011, 63(4-5):221-241.
10. Hirt M.N., Hansen A., Eschenhagen T. Cardiac tissue engineering: state of the art. Circ. Res. 2014, 114(2):354-367.
11. Zhao Y., Feric N.T., Thavandiran N., Nunes S.S., Radisic M. The role of tissue engineering and biomaterials in cardiac regenerative medicine. Can. J. Cardiol. 2014, 30(11):1307-1322.
12. Parker K.K., Ingber D.E. Extracellular matrix, mechanotransduction and structural hierarchies in heart tissue engineering. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2007, 362(1484):1267-1279.
13. Robinson T.F., Geraci M.A., Sonnenblick E.H., Factor S.M. Coiled perimysial fibers of papillary muscle in rat heart: morphology, distribution, and changes in configuration. Circ. Res. 1988, 63(3):577-592.
14. Kanzaki Y., Terasaki F., Okabe M., Fujita S., Katashima T., Otsuka K., Ishizaka N. Three-dimensional architecture of cardiomyocytes and connective tissue in human heart revealed by scanning electron microscopy. Circulation 2010, 122(19):1973-1974.
15. MacKenna D.A., Vaplon S.M., McCulloch A.D. Microstructural model of perimysial collagen fibers for resting myocardial mechanics during ventricular filling. Am. J. Physiol. 1997, 273(3 Pt 2):H1576-H1586.
16. Baicu C.F., Stroud J.D., Livesay V.A., Hapke E., Holder J., Spinale F.G., Zile M.R. Changes in extracellular collagen matrix alter myocardial systolic performance. Am. J. Physiol. Heart Circ. Physiol. 2003, 284(1):H122-H132.
17. Borg T.K., Ranson W.F., Moslehy F.A., Caulfield J.B. Structural basis of ventricular stiffness. Lab. Investig. 1981, 44(1):49-54.
18. Caulfield J.B., Borg T.K. The collagen network of the heart. Lab. Investig. 1979, 40(3):364-372.
19. Davidson M.M., Nesti C., Palenzuela L., Walker W.F., Hernandez E., Protas L., Hirano M., Isaac N.D. Novel cell lines derived from adult human ventricular cardiomyocytes. J. Mol. Cell. Cardiol. 2005, 39(1):133-147.
20. Parker K.K., Tan J., Chen C.S., Tung L. Myofibrillar architecture in engineered cardiac myocytes. Circ. Res. 2008, 103(4):340-342.
21. Badie N., Bursac N. Novel micropatterned cardiac cell cultures with realistic ventricular microstructure. Biophys. J. 2009, 96(9):3873-3885.
22. Kaneko T., Kojima K., Yasuda K. An on-chip cardiomyocyte cell network assay for stable drug screening regarding community effect of cell network size. Analyst 2007, 132(9):892-898.
23. Burridge P.W., Keller G., Gold J.D., Wu J.C. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell 2012, 10(1):16-28.
24. Figeac F., Lesault P.F., Le Coz O., Damy T., Souktani R., Trebeau C., Schmitt A., Ribot J., Mounier R., Guguin A., Manier C., Surenaud M., Hittinger L., Dubois-Rande J.L., Rodriguez A.M. Nanotubular crosstalk with distressed cardiomyocytes stimulates the paracrine repair function of mesenchymal stem cells. Stem Cells 2014, 32(1):216-230.
25. Haneef K., Naeem N., Khan I., Iqbal H., Kabir N., Jamall S., Zahid M., Salim A. Conditioned medium enhances the fusion capability of rat bone marrow mesenchymal stem cells and cardiomyocytes. Mol. Biol. Rep. 2014, 41(5):3099-3112.
26. Citro L., Naidu S., Hassan F., Kuppusamy M.L., Kuppusamy P., Angelos M.G., Khan M. Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction. PLoS One 2014, 9(12):e116281.
27. Dell'Era P., Benzoni P., Crescini E., Valle M., Xia E., Consiglio A., Memo M. Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes. World J. Stem Cells 2015, 7(2):329-342.
28. Hartman M.E., Dai D.F., Laflamme M.A. Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair. Adv. Drug Deliv. Rev. 2016, 96:3-17.
29. Mummery C., Ward-van Oostwaard D., Doevendans P., Spijker R., van den Brink S., Hassink R., van der Heyden M., Opthof T., Pera M., de la Riviere A.B., Passier R., Tertoolen L. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 2003, 107(21):2733-2740.
30. Kehat I., Kenyagin-Karsenti D., Snir M., Segev H., Amit M., Gepstein A., Livne E., Binah O., Itskovitz-Eldor J., Gepstein L. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 2001, 108(3):407-414.
31. Kattman S.J., Witty A.D., Gagliardi M., Dubois N.C., Niapour M., Hotta A., Ellis J., Keller G. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 2011, 8(2):228-240.
32. Zhang J., Klos M., Wilson G.F., Herman A.M., Lian X., Raval K.K., Barron M.R., Hou L., Soerens A.G., Yu J., Palecek S.P., Lyons G.E., Thomson J.A., Herron T.J., Jalife J., Kamp T.J. Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method. Circ. Res. 2012, 111(9):1125-1136.
33. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., Reinecke H., Xu C., Hassanipour M., Police S., O'Sullivan C., Collins L., Chen Y., Minami E., Gill E.A., Ueno S., Yuan C., Gold J., Murry C.E. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 2007, 25(9):1015-1024.
34. Lian X., Zhang J., Azarin S.M., Zhu K., Hazeltine L.B., Bao X., Hsiao C., Kamp T.J., Palecek S.P. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions. Nat. Protoc. 2013, 8(1):162-175.
35. Burridge P.W., Matsa E., Shukla P., Lin Z.C., Churko J.M., Ebert A.D., Lan F., Diecke S., Huber B., Mordwinkin N.M., Plews J.R., Abilez O.J., Cui B., Gold J.D., Wu J.C. Chemically defined generation of human cardiomyocytes. Nat. Methods 2014, 11(8):855-860.
36. Chen V.C., Couture S.M., Ye J., Lin Z., Hua G., Huang H.I., Wu J., Hsu D., Carpenter M.K., Couture L.A. Scalable GMP compliant suspension culture system for human ES cells. Stem Cell Res. 2012, 8(3):388-402.
37. Miyaoka Y., Chan A.H., Judge L.M., Yoo J., Huang M., Nguyen T.D., Lizarraga P.P., So P.L., Conklin B.R. Isolation of single-base genome-edited human iPS cells without antibiotic selection. Nat. Methods 2014, 11(3):291-293.
38. Wang Y., Zhang W.Y., Hu S., Lan F., Lee A.S., Huber B., Lisowski L., Liang P., Huang M., de Almeida P.E., Won J.H., Sun N., Robbins R.C., Kay M.A., Urnov F.D., Wu J.C. Genome editing of human embryonic stem cells and induced pluripotent stem cells with zinc finger nucleases for cellular imaging. Circ. Res. 2012, 111(12):1494-1503.
39. Taylor C.J., Bolton E.M., Pocock S., Sharples L.D., Pedersen R.A., Bradley J.A. Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 2005, 366(9502):2019-2025.
40. Stacey G.N., Crook J.M., Hei D., Ludwig T. Banking human induced pluripotent stem cells: lessons learned from embryonic stem cells?. Cell Stem Cell 2013, 13(4):385-388.
41. Laflamme M.A., Murry C.E. Heart regeneration. Nature 2011, 473(7347):326-335.
42. Robertson C., Tran D.D., George S.C. Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes. Stem Cells 2013, 31(5):829-837.
43. Yang X., Pabon L., Murry C.E. Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ. Res. 2014, 114(3):511-523.
44. Simpson D.G., Terracio L., Terracio M., Price R.L., Turner D.C., Borg T.K. Modulation of cardiac myocyte phenotype in vitro by the composition and orientation of the extracellular matrix. J. Cell. Physiol. 1994, 161(1):89-105.
45. Bursac N., Parker K.K., Iravanian S., Tung L. Cardiomyocyte cultures with controlled macroscopic anisotropy: a model for functional electrophysiological studies of cardiac muscle. Circ. Res. 2002, 91(12):e45-e54.
46. Motlagh D., Hartman T.J., Desai T.A., Russell B. Microfabricated grooves recapitulate neonatal myocyte connexin43 and N-cadherin expression and localization. J. Biomed. Mater. Res. A 2003, 67(1):148-157.
47. Wang P.Y., Yu J., Lin J.H., Tsai W.B. Modulation of alignment, elongation and contraction of cardiomyocytes through a combination of nanotopography and rigidity of substrates. Acta Biomater. 2011, 7(9):3285-3293.
48. Luna J.I., Ciriza J., Garcia-Ojeda M.E., Kong M., Herren A., Lieu D.K., Li R.A., Fowlkes C.C., Khine M., McCloskey K.E. Multiscale biomimetic topography for the alignment of neonatal and embryonic stem cell-derived heart cells. Tissue Eng. C Methods 2011, 17(5):579-588.
49. Chen A., Lieu D.K., Freschauf L., Lew V., Sharma H., Wang J., Nguyen D., Karakikes I., Hajjar R.J., Gopinathan A., Botvinick E., Fowlkes C.C., Li R.A., Khine M. Shrink-film configurable multiscale wrinkles for functional alignment of human embryonic stem cells and their cardiac derivatives. Adv. Mater. 2011, 23(48):5785-5791.
50. Kim D.H., Lipke E.A., Kim P., Cheong R., Thompson S., Delannoy M., Suh K.Y., Tung L., Levchenko A. Nanoscale cues regulate the structure and function of macroscopic cardiac tissue constructs. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(2):565-570.
51. Ma Z., Liu Q., Liu H., Yang H., Yun J.X., Eisenberg C., Borg T.K., Xu M., Gao B.Z. Laser-patterned stem-cell bridges in a cardiac muscle model for on-chip electrical conductivity analyses. Lab Chip 2012, 12(3):566-573.
52. Ma Z., Liu Q., Yang H., Runyan R.B., Eisenberg C.A., Xu M., Borg T.K., Markwald R., Wang Y., Gao B.Z. Laser patterning for the study of MSC cardiogenic differentiation at the single-cell level. Light Sci. Appl. 2013, 2.
53. Annabi N., Selimovic S., Acevedo Cox J.P., Ribas J., Afshar Bakooshli M., Heintze D., Weiss A.S., Cropek D., Khademhosseini A. Hydrogel-coated microfluidic channels for cardiomyocyte culture. Lab Chip 2013, 13(18):3569-3577.
54. Cimetta E., Pizzato S., Bollini S., Serena E., De Coppi P., Elvassore N. Production of arrays of cardiac and skeletal muscle myofibers by micropatterning techniques on a soft substrate. Biomed. Microdevices 2009, 11(2):389-400.
55. McDevitt T.C., Angello J.C., Whitney M.L., Reinecke H., Hauschka S.D., Murry C.E., Stayton P.S. In vitro generation of differentiated cardiac myofibers on micropatterned laminin surfaces. J. Biomed. Mater. Res. 2002, 60(3):472-479.
56. Agarwal A., Farouz Y., Nesmith A.P., Deravi L.F., McCain M.L., Parker K.K. Micropatterning Alginate Substrates for In Vitro Cardiovascular Muscle on a Chip. Adv. Funct. Mater. 2013, 23(30):3738-3746.
57. Camelliti P., Gallagher J.O., Kohl P., McCulloch A.D. Micropatterned cell cultures on elastic membranes as an in vitro model of myocardium. Nat. Protoc. 2006, 1(3):1379-1391.
58. Karp J.M., Yeo Y., Geng W., Cannizarro C., Yan K., Kohane D.S., Vunjak-Novakovic G., Langer R.S., Radisic M. A photolithographic method to create cellular micropatterns. Biomaterials 2006, 27(27):4755-4764.
59. Khademhosseini A., Eng G., Yeh J., Kucharczyk P.A., Langer R., Vunjak-Novakovic G., Radisic M. Microfluidic patterning for fabrication of contractile cardiac organoids. Biomed. Microdevices 2007, 9(2):149-157.
60. Thomas S.P., Bircher-Lehmann L., Thomas S.A., Zhuang J., Saffitz J.E., Kleber A.G. Synthetic strands of neonatal mouse cardiac myocytes: structural and electrophysiological properties. Circ. Res. 2000, 87(6):467-473.
61. Pong T., Adams W.J., Bray M.A., Feinberg A.W., Sheehy S.P., Werdich A.A., Parker K.K. Hierarchical architecture influences calcium dynamics in engineered cardiac muscle. Exp. Biol. Med. (Maywood) 2011, 236(3):366-373.
62. Thompson S.A., Copeland C.R., Reich D.H., Tung L. Mechanical coupling between myofibroblasts and cardiomyocytes slows electric conduction in fibrotic cell monolayers. Circulation 2011, 123(19):2083-2093.
63. Ribeiro M.C., Tertoolen L.G., Guadix J.A., Bellin M., Kosmidis G., D'Aniello C., Monshouwer-Kloots J., Goumans M.J., Wang Y.L., Feinberg A.W., Mummery C.L., Passier R. Functional maturation of human pluripotent stem cell derived cardiomyocytes in vitro--correlation between contraction force and electrophysiology. Biomaterials 2015, 51:138-150.
64. Serena E., Cimetta E., Zatti S., Zaglia T., Zagallo M., Keller G., Elvassore N. Micro-arrayed human embryonic stem cells-derived cardiomyocytes for in vitro functional assay. PLoS One 2012, 7(11):e48483.
65. Hwang Y.S., Chung B.G., Ortmann D., Hattori N., Moeller H.C., Khademhosseini A. Microwell-mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNT5a and WNT11. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(40):16978-16983.
66. Mohr J.C., Zhang J., Azarin S.M., Soerens A.G., de Pablo J.J., Thomson J.A., Lyons G.E., Palecek S.P., Kamp T.J. The microwell control of embryoid body size in order to regulate cardiac differentiation of human embryonic stem cells. Biomaterials 2010, 31(7):1885-1893.
67. Azarin S.M., Lian X., Larson E.A., Popelka H.M., de Pablo J.J., Palecek S.P. Modulation of Wnt/beta-catenin signaling in human embryonic stem cells using a 3-D microwell array. Biomaterials 2012, 33(7):2041-2049.
68. Myers F.B., Silver J.S., Zhuge Y., Beygui R.E., Zarins C.K., Lee L.P., Abilez O.J. Robust pluripotent stem cell expansion and cardiomyocyte differentiation via geometric patterning. Integr. Biol. (Camb.) 2013, 5(12):1495-1506.
69. Bauwens C.L., Peerani R., Niebruegge S., Woodhouse K.A., Kumacheva E., Husain M., Zandstra P.W. Control of human embryonic stem cell colony and aggregate size heterogeneity influences differentiation trajectories. Stem Cells 2008, 26(9):2300-2310.
70. Nazareth E.J., Ostblom J.E., Lucker P.B., Shukla S., Alvarez M.M., Oh S.K., Yin T., Zandstra P.W. High-throughput fingerprinting of human pluripotent stem cell fate responses and lineage bias. Nat. Methods 2013, 10(12):1225-1231.
71. Warmflash A., Sorre B., Etoc F., Siggia E.D., Brivanlou A.H. A method to recapitulate early embryonic spatial patterning in human embryonic stem cells. Nat. Methods 2014, 11(8):847-854.
72. Ma Z., Wang J., Loskill P., Huebsch N., Koo S., Svedlund F.L., Marks N., Hua E.W., Grigoropoulos C.P., Conklin B.R., Healy K.E. Self-organizing human cardiac microchambers mediated by geometric confinement. Nat. Commun. 2015, 6:7413.
73. Geisse N.A., Sheehy S.P., Parker K.K. Control of myocyte remodeling in vitro with engineered substrates. In Vitro Cell. Dev. Biol. Anim. 2009, 45(7):343-350.
74. Bray M.A., Sheehy S.P., Parker K.K. Sarcomere alignment is regulated by myocyte shape. Cell Motil. Cytoskeleton 2008, 65(8):641-651.
75. Bray M.A., Adams W.J., Geisse N.A., Feinberg A.W., Sheehy S.P., Parker K.K. Nuclear morphology and deformation in engineered cardiac myocytes and tissues. Biomaterials 2010, 31(19):5143-5150.
76. Eschenhagen T., Fink C., Remmers U., Scholz H., Wattchow J., Weil J., Zimmermann W., Dohmen H.H., Schafer H., Bishopric N., Wakatsuki T., Elson E.L. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J. 1997, 11(8):683-694.
77. Zimmermann W.H., Fink C., Kralisch D., Remmers U., Weil J., Eschenhagen T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol. Bioeng. 2000, 68(1):106-114.
78. Zimmermann W.H., Melnychenko I., Wasmeier G., Didie M., Naito H., Nixdorff U., Hess A., Budinsky L., Brune K., Michaelis B., Dhein S., Schwoerer A., Ehmke H., Eschenhagen T. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat. Med. 2006, 12(4):452-458.
79. Hansen A., Eder A., Bonstrup M., Flato M., Mewe M., Schaaf S., Aksehirlioglu B., Schwoerer A.P., Uebeler J., Eschenhagen T. Development of a drug screening platform based on engineered heart tissue. Circ. Res. 2010, 107(1):35-44.
80. Schaaf S., Shibamiya A., Mewe M., Eder A., Stohr A., Hirt M.N., Rau T., Zimmermann W.H., Conradi L., Eschenhagen T., Hansen A. Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PLoS One 2011, 6(10).
81. Boudou T., Legant W.R., Mu A., Borochin M.A., Thavandiran N., Radisic M., Zandstra P.W., Epstein J.A., Margulies K.B., Chen C.S. A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues. Tissue Eng. A 2012, 18(9-10):910-919.
82. Hinson J.T., Chopra A., Nafissi N., Polacheck W.J., Benson C.C., Swist S., Gorham J., Yang L., Schafer S., Sheng C.C., Haghighi A., Homsy J., Hubner N., Church G., Cook S.A., Linke W.A., Chen C.S., Seidman J.G., Seidman C.E. HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy. Science 2015, 349(6251):982-986.
83. Turnbull I.C., Karakikes I., Serrao G.W., Backeris P., Lee J.J., Xie C., Senyei G., Gordon R.E., Li R.A., Akar F.G., Hajjar R.J., Hulot J.S., Costa K.D. Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium. FASEB J. 2014, 28(2):644-654.
84. Thavandiran N., Dubois N., Mikryukov A., Masse S., Beca B., Simmons C.A., Deshpande V.S., McGarry J.P., Chen C.S., Nanthakumar K., Keller G.M., Radisic M., Zandstra P.W. Design and formulation of functional pluripotent stem cell-derived cardiac microtissues. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(49):E4698-E4707.
85. Liau B., Christoforou N., Leong K.W., Bursac N. Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. Biomaterials 2011, 32(35):9180-9187.
86. Zhang D., Shadrin I.Y., Lam J., Xian H.Q., Snodgrass H.R., Bursac N. Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials 2013, 34(23):5813-5820.
87. Maidhof R., Tandon N., Lee E.J., Luo J., Duan Y., Yeager K., Konofagou E., Vunjak-Novakovic G. Biomimetic perfusion and electrical stimulation applied in concert improved the assembly of engineered cardiac tissue. J. Tissue Eng. Regen. Med. 2012, 6(10):e12-e23.
88. Kai D., Prabhakaran M.P., Jin G., Ramakrishna S. Guided orientation of cardiomyocytes on electrospun aligned nanofibers for cardiac tissue engineering. J. Biomed. Mater. Res. B Appl. Biomater. 2011, 98(2):379-386.
89. Orlova Y., Magome N., Liu L., Chen Y., Agladze K. Electrospun nanofibers as a tool for architecture control in engineered cardiac tissue. Biomaterials 2011, 32(24):5615-5624.
90. Kenar H., Kose G.T., Toner M., Kaplan D.L., Hasirci V. A 3D aligned microfibrous myocardial tissue construct cultured under transient perfusion. Biomaterials 2011, 32(23):5320-5329.
91. Badrossamay M.R., Balachandran K., Capulli A.K., Golecki H.M., Agarwal A., Goss J.A., Kim H., Shin K., Parker K.K. Engineering hybrid polymer-protein super-aligned nanofibers via rotary jet spinning. Biomaterials 2014, 35(10):3188-3197.
92. Ma Z., Koo S., Finnegan M.A., Loskill P., Huebsch N., Marks N.C., Conklin B.R., Grigoropoulos C.P., Healy K.E. Three-dimensional filamentous human diseased cardiac tissue model. Biomaterials 2014, 35(5):1367-1377.
93. Nunes S.S., Miklas J.W., Liu J., Aschar-Sobbi R., Xiao Y., Zhang B., Jiang J., Masse S., Gagliardi M., Hsieh A., Thavandiran N., Laflamme M.A., Nanthakumar K., Gross G.J., Backx P.H., Keller G., Radisic M. Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat. Methods 2013, 10(8):781-787.
94. Miklas J.W., Nunes S.S., Sofla A., Reis L.A., Pahnke A., Xiao Y., Laschinger C., Radisic M. Bioreactor for modulation of cardiac microtissue phenotype by combined static stretch and electrical stimulation. Biofabrication 2014, 6(2):024113.
95. Xiao Y., Zhang B., Liu H., Miklas J.W., Gagliardi M., Pahnke A., Thavandiran N., Sun Y., Simmons C., Keller G., Radisic M. Microfabricated perfusable cardiac biowire: a platform that mimics native cardiac bundle. Lab Chip 2014, 14(5):869-882.
96. Grosberg A., Alford P.W., McCain M.L., Parker K.K. Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip. Lab Chip 2011, 11(24):4165-4173.
97. Agarwal A., Goss J.A., Cho A., McCain M.L., Parker K.K. Microfluidic heart on a chip for higher throughput pharmacological studies. Lab Chip 2013, 13(18):3599-3608.
98. Feinberg A.W., Ripplinger C.M., van der Meer P., Sheehy S.P., Domian I., Chien K.R., Parker K.K. Functional differences in engineered myocardium from embryonic stem cell-derived versus neonatal cardiomyocytes. Stem Cell Rep. 2013, 1(5):387-396.
99. McCain M.L., Sheehy S.P., Grosberg A., Goss J.A., Parker K.K. Recapitulating maladaptive, multiscale remodeling of failing myocardium on a chip. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(24):9770-9775.
100. Wang G., McCain M.L., Yang L., He A., Pasqualini F.S., Agarwal A., Yuan H., Jiang D., Zhang D., Zangi L., Geva J., Roberts A.E., Ma Q., Ding J., Chen J., Wang D.Z., Li K., Wang J., Wanders R.J., Kulik W., Vaz F.M., Laflamme M.A., Murry C.E., Chien K.R., Kelley R.I., Church G.M., Parker K.K., Pu W.T. Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat. Med. 2014, 20(6):616-623.
101. Mosadegh B., Dabiri B.E., Lockett M.R., Derda R., Campbell P., Parker K.K., Whitesides G.M. Three-dimensional paper-based model for cardiac ischemia. Adv. Healthc. Mater. 2014, 3(7):1036-1043.
102. Mathur A., Loskill P., Shao K., Huebsch N., Hong S., Marcus S.G., Marks N., Mandegar M., Conklin B.R., Lee L.P., Healy K.E. Human iPSC-based cardiac microphysiological system for drug screening applications. Sci. Rep. 2015, 5:8883.
103. Lundy S.D., Zhu W.Z., Regnier M., Laflamme M.A. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev. 2013, 22(14):1991-2002.
104. Abate A.R., Lee D., Do T., Holtze C., Weitz D.A. Glass coating for PDMS microfluidic channels by sol-gel methods. Lab Chip 2008, 8(4):516-518.
105. Sun L., Luo Y., Gao Z., Zhao W., Lin B. Easy-to-fabricate thin-film coating on PDMS substrate with super hydrophilicity and stability. Electrophoresis 2015, 36(6):889-892.
106. Collins F.S., Varmus H. A new initiative on precision medicine. N. Engl. J. Med. 2015, 372(9):793-795.
107. Ashley E.A. The Precision Medicine Initiative: A New National Effort. JAMA 2015, 313(21):2119-2120.
108. Tsimberidou A.M., Eggermont A.M., Schilsky R.L. Precision cancer medicine: the future is now, only better. Am. Soc. Clin. Oncol. Educ. Book 2014, 61-69.